Question 1

Can a person with a partial deletion that spares the LETM1 gene still develop Wolf-Hirschhorn syndrome?

Accepted Answer

Yes, Wolf-Hirschhorn syndrome is caused by the deletion of a specific region on chromosome 4 (4p16.3), but the severity of symptoms depends on which genes are lost. If the deletion is very small and does not include the LETM1 gene or other critical neighboring genes, the individual may have milder symptoms or even be asymptomatic. However, if the deletion includes LETM1, the risk for seizures and mitochondrial dysfunction-related neurological issues increases. Genetic testing, such as chromosomal microarray, is required to determine the exact size and location of the deletion.

Question 2

How does the loss of LETM1 affect brain electrical activity, and why are seizures a common feature?

Accepted Answer

The LETM1 protein helps regulate calcium ions within mitochondria, which is crucial for maintaining cellular energy balance and signaling. When this gene is deleted, the resulting mitochondrial abnormalities can disrupt the normal electrical stability of neurons. This disruption makes brain cells more prone to hyperexcitability, leading to abnormal electrical discharges known as seizures. In many individuals with Wolf-Hirschhorn syndrome, these seizures begin in infancy and can be difficult to control, requiring careful neurological monitoring and medication adjustments.

Question 3

What specific symptoms in an infant might suggest a deletion involving the LETM1 gene rather than other chromosomal abnormalities?

Accepted Answer

While LETM1 deletion is part of the broader Wolf-Hirschhorn syndrome (4p deletion), clinicians look for a specific combination of features. Key indicators include a distinctive facial appearance often described as a "Greek warrior helmet" profile, significant growth delay (both prenatal and postnatal), and early-onset seizures. Because the LETM1 protein is involved in mitochondrial calcium transport, the presence of severe neurological issues like intractable seizures alongside the characteristic facial features strongly points toward a deletion in the 4p16.3 region where LETM1 is located.

Question 4

Is there a specific treatment for the mitochondrial dysfunction associated with LETM1 loss?

Accepted Answer

Currently, there is no specific cure for the mitochondrial structural changes caused by LETM1 deletion. Treatment is supportive and focuses on managing the symptoms of Wolf-Hirschhorn syndrome. This includes anti-seizure medications for epilepsy, physical and occupational therapy for developmental delays, and regular monitoring of growth and nutrition. Researchers are investigating how mitochondrial health impacts neurological outcomes, but clinical management remains symptomatic rather than targeting the gene defect directly.

LETM1 gene

Normal Function

Health Conditions Related to Genetic Changes

Wolf-Hirschhorn syndrome

Other Names for This Gene

Frequently Asked Questions